Journey Medical (DERM) EBITDA Margin Growth (3y) (2023 - 2026)
Journey Medical (DERM) EBITDA Margin Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.51 Bn | 87.64 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 36.00 Bn | 32.26 Bn | 1.97 Bn | 1,673.00 |
| 3 | Zoetis | 32.61 Bn | 30.67 Bn | 1.62 Bn | -37.00 |
| 4 | Takeda Pharmaceutical | 27.49 Bn | 23.43 Bn | 4.39 Bn | -5,395.00 |
| 5 | United Therapeutics | 23.05 Bn | 20.90 Bn | 648.10 Mn | -1,442.00 |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - | - |
| 7 | Viatris | 20.26 Bn | 18.46 Bn | 1.16 Bn | -1,299.00 |
| 8 | Neurocrine Biosciences | 17.79 Bn | 16.47 Bn | 800.70 Mn | 5,091.00 |
| 9 | Elanco Animal Health | 12.64 Bn | 12.21 Bn | 785.00 Mn | 5,193.00 |
| 10 | Journey Medical | 173.11 Mn | 145.89 Mn | 9.70 Mn | 6,922.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6,922.00 |
| Dec 31, 2025 | 6,002.00 |
| Sep 30, 2025 | 4,992.00 |
| Jun 30, 2025 | 1,988.00 |
| Mar 31, 2025 | -2,103.00 |
| Dec 31, 2024 | 6,941.00 |
| Sep 30, 2024 | 4,470.00 |
| Jun 30, 2024 | 7,032.00 |
| Mar 31, 2024 | -8,289.00 |
| Dec 31, 2023 | -4,021.00 |
| Sep 30, 2023 | 4,740.00 |